AZoLifeSciences on MSN4h
New Computational Approach Speeds Up Genetic Variant Analysis for Disease Risk
Argonne computer scientists enabled a new research modality in the search for causality among genetic variants for a given ...
abcnews4 on MSN8h
Gene therapy among cutting-edge treatments at MUSC's new sickle cell center in Charleston
MUSC health has established the Rena N. Grant Sickle Cell Center to help treat those suffering from sickle cell disease. This ...
High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models
The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.
MUSC expands gene therapy, resources for Sickle Cell ‘warriors’ in South Carolina
The Medical University of South Carolina is expanding its access to state-supported Sickle Cell programs for “warriors,” or ...
sicklecellanemianews16h
1st SCD patient outside US receives gene-editing therapy Casgevy
An SCD patient in Bahrain received the gene-editing therapy Casgevy, marking the first time the treatment has been given outside the U.S.
PharmiWeb22h
Gene Editing Market: Comprehensive Analysis and Forecast 2025–2035
The global Gene Editing Market was valued at $5.1 billion in 2022 and is projected to reach $16.2 billion by 2030, growing at ...